Scientifically validated pharmaceuticals engineered for efficacy, safety, and global compliance.
Hext organizes its therapeutic offering to serve three distinct demand channels — regulated-market export, emerging-market access, and government institutional tender — each with tailored packaging, documentation, and pricing architecture.
WHO Essential Medicines List-aligned formulations for government and public health procurement. These products are manufactured to meet the analytical rigor and documentation standards required by national drug procurement agencies and multilateral health organizations.
Oncology-supportive care, anti-infective, and chronic disease management products manufactured to regulated-market documentation standards. These formulations carry full CoPP-ready dossiers for rapid registration in new destination countries.
Standardized extracts and formulations bridging traditional medicine and modern quality control. These products undergo the same stability-indicating analytical methods and bioequivalence-driven development pathways as conventional pharmaceuticals.
Products maintained with CoPP-ready dossiers for rapid registration in new destination countries. These formulations are structured for simultaneous compliance with CDSCO domestic requirements and destination-market regulatory dossiers.
Specific product names, molecules, and indications should be added once the pipeline is finalized and regulatory approvals are confirmed, to ensure claims remain compliant with destination-market advertising regulations.
Contact our business development team for detailed product catalogues, pricing, and regulatory documentation.
